Skip to main content
Total Market Cap: $48,319,121,949 Volume (24h): $759,890,563

22nd Century Group Inc.

22nd Century Group Inc. (XXII) logo
Rank 26
About

The main focus of American company 22nd Century Group is the research, development, and production of low-nicotine smoking solutions. However, in conjunction with a wholly-owned subsidiary Botanical Genetics, they also have a license to supply patients with cannabinoid-based medicine. 22nd Century Group also owns Goodrich Tobacco Company, NASCO Products, and Heracles Pharmaceuticals.

Website
$2.4900
USD
-6.85%
Market cap
$312,903,200
Total volume
$10,399,811
Shares outstanding
125,663,936
Rank 26
Website
About

The main focus of American company 22nd Century Group is the research, development, and production of low-nicotine smoking solutions. However, in conjunction with a wholly-owned subsidiary Botanical Genetics, they also have a license to supply patients with cannabinoid-based medicine. 22nd Century Group also owns Goodrich Tobacco Company, NASCO Products, and Heracles Pharmaceuticals.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
NYSE
XXII
$10,399,811
100%
$2.4900
Chart
Social media
Tweets by @_xxiicentury
22nd Century Group Inc.

Share widget

Copy widget code
Subscribe to our newsletter